These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
90 related items for PubMed ID: 20150623
41. Promoter hypermethylation and silencing of CHFR mitotic stress checkpoint gene in human gastric cancers. Kang HC, Kim IJ, Park JH, Shin Y, Park HW, Ku JL, Yang HK, Lee KU, Choe KJ, Park JG. Oncol Rep; 2004 Jul; 12(1):129-33. PubMed ID: 15201973 [Abstract] [Full Text] [Related]
42. Methylation of the homeobox gene, HOPX, is frequently detected in poorly differentiated colorectal cancer. Harada Y, Kijima K, Shinmura K, Sakata M, Sakuraba K, Yokomizo K, Kitamura Y, Shirahata A, Goto T, Mizukami H, Saito M, Kigawa G, Nemoto H, Hibi K. Anticancer Res; 2011 Sep; 31(9):2889-92. PubMed ID: 21868534 [Abstract] [Full Text] [Related]
43. Low expression of reduced folate carrier-1 and folylpolyglutamate synthase correlates with lack of a deleted in colorectal carcinoma mRNA splice variant in normal-appearing mucosa of colorectal carcinoma patients. Wettergren Y, Odin E, Nilsson S, Willen R, Carlsson G, Gustavsson B. Cancer Detect Prev; 2005 Sep; 29(4):348-55. PubMed ID: 16122883 [Abstract] [Full Text] [Related]
44. Effect of promoter methylation of multidrug resistance 1 (MDR1) gene in gastric carcinogenesis. Tahara T, Arisawa T, Shibata T, Yamashita H, Yoshioka D, Hirata I. Anticancer Res; 2009 Jan; 29(1):337-41. PubMed ID: 19331170 [Abstract] [Full Text] [Related]
45. Promoter methylation of cancer-related genes in gastric carcinoma. Poplawski T, Tomaszewska K, Galicki M, Morawiec Z, Blasiak J. Exp Oncol; 2008 Jun; 30(2):112-6. PubMed ID: 18566573 [Abstract] [Full Text] [Related]
46. Methylation of the UNC5C gene is frequently detected in hepatocellular carcinoma. Hibi K, Sakuraba K, Shirahata A, Goto T, Saito M, Ishibashi K, Kigawa G, Nemoto H, Sanada Y. Hepatogastroenterology; 2012 Jun; 59(120):2573-5. PubMed ID: 23178624 [Abstract] [Full Text] [Related]
47. PGP9.5 was less frequently methylated in advanced gastric carcinoma. Mizukami H, Goto T, Kitamura Y, Sakata M, Saito M, Ishibashi K, Kigawa G, Nemoto H, Sanada Y, Hibi K. Hepatogastroenterology; 2009 Jun; 56(94-95):1576-9. PubMed ID: 19950834 [Abstract] [Full Text] [Related]
48. Demethylation of the CD133 gene is frequently detected in early gastric carcinoma. Hibi K, Sakata M, Kitamura YH, Sakuraba K, Shirahata A, Goto T, Mizukami H, Saito M, Ishibashi K, Kigawa G, Nemoto H, Sanada Y. Anticancer Res; 2010 Apr; 30(4):1201-3. PubMed ID: 20530428 [Abstract] [Full Text] [Related]
49. Reprimo as a potential biomarker for early detection in gastric cancer. Bernal C, Aguayo F, Villarroel C, Vargas M, Díaz I, Ossandon FJ, Santibáñez E, Palma M, Aravena E, Barrientos C, Corvalan AH. Clin Cancer Res; 2008 Oct 01; 14(19):6264-9. PubMed ID: 18829507 [Abstract] [Full Text] [Related]
50. Quantitative assessment of RUNX3 methylation in neoplastic and non-neoplastic gastric epithelia using a DNA microarray. So K, Tamura G, Honda T, Homma N, Endoh M, Togawa N, Nishizuka S, Motoyama T. Pathol Int; 2006 Oct 01; 56(10):571-5. PubMed ID: 16984612 [Abstract] [Full Text] [Related]
51. Aberrant methylation of the CHFR gene in advanced hepatocellular carcinoma. Sakai M, Hibi K, Kanazumi N, Nomoto S, Inoue S, Takeda S, Nakao A. Hepatogastroenterology; 2005 Oct 01; 52(66):1854-7. PubMed ID: 16334792 [Abstract] [Full Text] [Related]
52. Methylation of the TFPI2 gene is frequently detected in advanced gastric carcinoma. Hibi K, Goto T, Kitamura YH, Sakuraba K, Shirahata A, Mizukami H, Saito M, Ishibashi K, Kigawa G, Nemoto H, Sanada Y. Anticancer Res; 2010 Oct 01; 30(10):4131-3. PubMed ID: 21036731 [Abstract] [Full Text] [Related]
53. [DNA methylation of microRNA-34b/c and microRNA-124a in gastric cancer]. Li Y, Yue HY, Liu WT, Fang WL. Zhonghua Yi Xue Za Zhi; 2011 Jun 21; 91(23):1640-2. PubMed ID: 21914401 [Abstract] [Full Text] [Related]
54. Down-regulation of EGFL8: a novel biomarker for advanced gastric cancer. Wu F, Shirahata A, Sakuraba K, Kitamura Y, Goto T, Saito M, Ishibashi K, Kigawa G, Nemoto H, Sanada Y, Hibi K. Anticancer Res; 2011 Oct 21; 31(10):3377-80. PubMed ID: 21965749 [Abstract] [Full Text] [Related]
55. Aberrant methylation of the HACE1 gene is frequently detected in advanced colorectal cancer. Hibi K, Sakata M, Sakuraba K, Shirahata A, Goto T, Mizukami H, Saito M, Ishibashi K, Kigawa G, Nemoto H, Sanada Y. Anticancer Res; 2008 Oct 21; 28(3A):1581-4. PubMed ID: 18630515 [Abstract] [Full Text] [Related]
56. Study of loss of heterozygosity at DCC and APC/MCC genetic loci of gastric cancer. Wang D, Fang D, Luo Y, Lu R, Liu W. Chin Med Sci J; 1999 Jun 21; 14(2):107-11. PubMed ID: 12901620 [Abstract] [Full Text] [Related]
57. Potential role and chronology of abnormal expression of the Deleted in Colon Cancer (DCC) and the p53 proteins in the development of gastric cancer. Graziano F, Cascinu S, Staccioli MP, Catalano V, Rossi MC, Baldelli AM, Giordani P, Muretto P, Catalano G. BMC Cancer; 2001 Jun 21; 1():9. PubMed ID: 11518545 [Abstract] [Full Text] [Related]
58. WNT5A gene is aberrantly methylated from the early stages of colorectal cancers. Hibi K, Mizukami H, Goto T, Kitamura Y, Sakata M, Saito M, Ishibashi K, Kigawa G, Nemoto H, Sanada Y. Hepatogastroenterology; 2009 Jun 21; 56(93):1007-9. PubMed ID: 19760930 [Abstract] [Full Text] [Related]
59. Loss of heterozygosity and loss of expression of the DCC gene in gastric cancer. Fang DC, Jass JR, Wang DX. J Clin Pathol; 1998 Aug 21; 51(8):593-6. PubMed ID: 9828817 [Abstract] [Full Text] [Related]
60. Decreased expression of DCC mRNA in gastric and colorectal cancer. Kataoka M, Okabayashi T, Orita K. Surg Today; 1995 Aug 21; 25(12):1001-7. PubMed ID: 8645930 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]